These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 6871460)

  • 1. [Production of antibodies to influenza virus A by human lymphoid cells in vitro].
    Ispolatova AV; Korchanova NL; Medvenskiĭ BV; Pluzhnikov MS; Al-Tamimi FA
    Biull Eksp Biol Med; 1983 Jul; 96(7):81-3. PubMed ID: 6871460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues.
    Nguyen HH; Moldoveanu Z; Novak MJ; van Ginkel FW; Ban E; Kiyono H; McGhee JR; Mestecky J
    Virology; 1999 Feb; 254(1):50-60. PubMed ID: 9927573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza virus.
    Yarchoan R; Murphy BR; Strober W; Clements ML; Nelson DL
    J Immunol; 1981 Nov; 127(5):1958-63. PubMed ID: 7299119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific anti-influenza virus antibody production in vitro by human peripheral blood mononuclear cells.
    Yarchoan R; Murphy BR; Strober W; Schneider HS; Nelson DL
    J Immunol; 1981 Dec; 127(6):2588-94. PubMed ID: 6975330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomical environment as a determinant in viral immunity.
    Doherty PC
    J Immunol; 1995 Aug; 155(3):1023-7. PubMed ID: 7636177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization.
    Marshall D; Sealy R; Sangster M; Coleclough C
    J Immunol; 1999 Nov; 163(9):4673-82. PubMed ID: 10528164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2).
    Tang M; Harp JA; Wesley RD
    Arch Virol; 2002 Nov; 147(11):2125-41. PubMed ID: 12417948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization.
    Coffin SE; Clark SL; Bos NA; Brubaker JO; Offit PA
    J Immunol; 1999 Sep; 163(6):3064-70. PubMed ID: 10477570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. II. Measurement of intestinal antibodies by radioimmunoassay.
    Chau PY; Tsang RS; Lam SK; La Brooy JT; Rowley D
    Clin Exp Immunol; 1981 Dec; 46(3):515-20. PubMed ID: 7337978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serological survey on antibodies to influenza A viruses subtype H1, H3, H5 and H9 of population in Shanghai].
    Lv XH; Jiang CY; Zhou YB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):302. PubMed ID: 19642392
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
    Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
    Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa.
    Brokstad KA; Eriksson JC; Cox RJ; Tynning T; Olofsson J; Jonsson R; Davidsson A
    J Infect Dis; 2002 Apr; 185(7):878-84. PubMed ID: 11920311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of an attenuated influenza A (H3N2) strain "KO-1" by recombination with A/Okuda/57 (H2N2) followed by selection of inhibitor-resistant virus.
    Yamada A; Okuno Y; Takahashi M; Nakajima K
    Biken J; 1980 Mar; 23(1):25-32. PubMed ID: 7437002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
    Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
    J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of the immune response to influenza vaccine by acetylsalicylic acid: a clinical trial in a geriatric population.
    Hsia J; Tang T; Parrott M; Rogalla K
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):677-83. PubMed ID: 7746030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season.
    Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M
    J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine.
    Mbawuike IN; Piedra PA; Cate TR; Couch RB
    J Med Virol; 1996 Oct; 50(2):105-11. PubMed ID: 8915874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy for selective, CD4+ T cell-independent activation of virus-specific memory B cells for limiting dilution analysis.
    Li X; Vanitha DJ; Joo HM; He Y; Rouse BT; Sangster MY
    J Immunol Methods; 2006 Jun; 313(1-2):110-8. PubMed ID: 16730022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope.
    Deckhut AM; Allan W; McMickle A; Eichelberger M; Blackman MA; Doherty PC; Woodland DL
    J Immunol; 1993 Sep; 151(5):2658-66. PubMed ID: 7689611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.